Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
Olema Pharmaceuticals (Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on targeted breast cancer therapies, announced the appointment of Dr. Prakash Raman to its Board of Directors. Dr. Raman brings extensive leadership and business development expertise from prior biotech and pharma roles. The appointment comes as Olema progresse…